Blood cell production via activation of the hemoglobin scavenger receptor
CA 2441566 C · Owner: Mueller, Susan · Inventors: Matthews, Kathryn Emma; Bell, David; Mueller, Susan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions for stimulating the growth proliferation, differentiation and/or mobilization of stem and/or progenitor cells are described. The method involves administering an effective amount of a substance which can activate the CD163 hemoglobin scavenger receptor signal transduction pathway. The methods and compositions are useful in stimulating hematopoiesis and in treating a wide range of conditions including cytopenias anemias and for use in preparing cells for transplantation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 26, 2002 and granted February 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.